<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37722062</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>39</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Causal ALS genes impact the MHC class II antigen presentation pathway.</ArticleTitle><Pagination><StartPage>e2305756120</StartPage><MedlinePgn>e2305756120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2305756120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2305756120</ELocationID><Abstract><AbstractText>Mutations in RNA/DNA-binding proteins cause amyotrophic lateral sclerosis (ALS), but the underlying disease mechanisms remain unclear. Here, we report that a set of ALS-associated proteins, namely FUS, EWSR1, TAF15, and MATR3, impact the expression of genes encoding the major histocompatibility complex II (MHC II) antigen presentation pathway. Both subunits of the MHC II heterodimer, HLA-DR, are down-regulated in ALS gene knockouts/knockdown in HeLa and human microglial cells, due to loss of the MHC II transcription factor CIITA. Importantly, hematopoietic progenitor cells (HPCs) derived from human embryonic stem cells bearing the FUS<sup>R495X</sup> mutation and HPCs derived from C9ORF72 ALS patient induced pluripotent stem cells also exhibit disrupted MHC II expression. Given that HPCs give rise to numerous immune cells, our data raise the possibility that loss of the MHC II pathway results in global failure of the immune system to protect motor neurons from damage that leads to ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Binkai</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zt&#xfc;rk</LastName><ForeName>Muhammet M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paraggio</LastName><ForeName>Christina L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leonard</LastName><ForeName>Claudia E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanita</LastName><ForeName>Maria E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dastpak</LastName><ForeName>Mahtab</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Jeremy D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coady</LastName><ForeName>Jordan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiuchun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Harvard Medical School Cell Biology Initiative for Genome Editing and Neurodegeneration, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gygi</LastName><ForeName>Steven P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Gonzalez</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5480-6312</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44196.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Shanye</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reed</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM122524</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C518587">MATR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034521">Nuclear Matrix-Associated Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Proc Natl Acad Sci U S A. 2023 Oct 24;120(43):e2315240120</RefSource><PMID Version="1">37819987</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017951" MajorTopicYN="N">Antigen Presentation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005802" MajorTopicYN="N">Genes, MHC Class II</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008285" MajorTopicYN="N">Major Histocompatibility Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034521" MajorTopicYN="N">Nuclear Matrix-Associated Proteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">C9ORF72</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">MHC II</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>15</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37722062</ArticleId><ArticleId IdType="pmc">PMC10523463</ArticleId><ArticleId IdType="doi">10.1073/pnas.2305756120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor J. P., Brown R. H., Cleveland D. W., Decoding ALS: From genes to mechanism. Nature 539, 197&#x2013;206 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., et al. , ALS genetics, mechanisms, and therapeutics: Where are we now? Front. Neurosci. 13, 1310 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., et al. , Gains, losses, and implications for future therapies. Neuron 108, 822&#x2013;842 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D., Vaz A. R., Microglia centered pathogenesis in ALS: Insights in cell interconnectivity. Front. Cell. Neurosci. 8, 117 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033073</ArticleId><ArticleId IdType="pubmed">24904276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooten K. G., Beers D. R., Zhao W., Appel S. H., Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics 12, 364&#x2013;375 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4404435</ArticleId><ArticleId IdType="pubmed">25567201</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherry J. D., Olschowka J. A., O&#x2019;Banion M. K., Neuroinflammation and M2 microglia: The good, the bad, and the inflamed. J. Neuroinflammation 11, 98 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4060849</ArticleId><ArticleId IdType="pubmed">24889886</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V., et al. , The loss of TBK1 kinase activity in motor neurons or in all cell types differentially impacts ALS disease progression in SOD1 mice. Neuron 106, 789&#x2013;805.e5 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32220666</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick N. D., et al. , Distinct roles for motor neuron autophagy early and late in the SOD1 G93A mouse model of ALS. Proc. Natl. Acad. Sci. U.S.A. 114, E8294&#x2013;E8303 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Benarroch E., What is the role of oligodendrocytes in amyotrophic lateral sclerosis? Neurology 97, 776&#x2013;779 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34663738</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Komine O., The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 126, 31&#x2013;38 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke B. E., Patani R., The microglial component of amyotrophic lateral sclerosis. Brain 143, 3526&#x2013;3539 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805793</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn D., Sargsyan S., Monk P. N., Shaw P. J., Astrocyte function and role in motor neuron disease: A future therapeutic target? Glia 57, 1251&#x2013;1264 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19373940</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso M. C., et al. , The dual role of microglia in ALS: Mechanisms and therapeutic approaches. Front. Aging Neurosci. 9, 242 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridler C., Reactive microglia protect neurons in ALS. Nat. Rev. Neurol. 14, 253&#x2013;253 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29521336</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller K. J., et al. , Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 21, 329&#x2013;340 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi C., et al. , Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis. Cell Death Dis. 9, 250 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833860</ArticleId><ArticleId IdType="pubmed">29445154</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;land L.-C., et al. , Immunity in amyotrophic lateral sclerosis: Blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2, fcaa124 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585698</ArticleId><ArticleId IdType="pubmed">33134918</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I. M., et al. , T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. U.S.A. 105, 17913&#x2013;17918 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2581614</ArticleId><ArticleId IdType="pubmed">18997009</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee R., et al. , Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS One 3, e2740 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2481277</ArticleId><ArticleId IdType="pubmed">18648532</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., et al. , T cell independent mechanism for copolymer-1-induced neuroprotection. Eur. J. Immunol. 37, 3143&#x2013;3154 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17948266</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanabe S., Yamashita T., B-1a lymphocytes promote oligodendrogenesis during brain development. Nat. Neurosci. 21, 506&#x2013;516 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29507409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega S. B., et al. , B cells migrate into remote brain areas and support neurogenesis and functional recovery after focal stroke in mice. Proc. Natl. Acad. Sci. U.S.A. 117, 4983&#x2013;4993 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7060723</ArticleId><ArticleId IdType="pubmed">32051245</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitkovic L., Maeda S., Sternberg E., Anti-inflammatory cytokines: Expression and action in the brain. Neuroimmunomodulation 9, 295&#x2013;312 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">12045357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ousman S. S., Kubes P., Immune surveillance in the central nervous system. Nat. Neurosci. 15, 1096&#x2013;1101 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097282</ArticleId><ArticleId IdType="pubmed">22837040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F. J., Yeo G. W., Genetic mutations in RNA-binding proteins and their roles in ALS. Hum. Genet. 136, 1193&#x2013;1214 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi B., et al. , Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins. Sci. Rep. 8, 8755 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5993797</ArticleId><ArticleId IdType="pubmed">29884807</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T., et al. , FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2, 799&#x2013;806 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3483417</ArticleId><ArticleId IdType="pubmed">23022481</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi B., et al. , The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex. Nucleic Acids Res. 46, 11939&#x2013;11951 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6294556</ArticleId><ArticleId IdType="pubmed">30398641</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis T., Reed R., An extensive network of coupling among gene expression machines. Nature 416, 499&#x2013;506 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11932736</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed R., Hurt E., A conserved mRNA export machinery coupled to pre-mRNA splicing. Cell 108, 523&#x2013;531 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11909523</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosonina E., Blencowe B. J., Gene expression: The close coupling of transcription and splicing. Curr. Biol. 12, R319&#x2013;R321 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12007432</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J. C., Cech T. R., Parker R. R., Biochemical properties and biological functions of FET proteins. Annu. Rev. Biochem. 84, 355&#x2013;379 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9188303</ArticleId><ArticleId IdType="pubmed">25494299</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolotti A., Bell B., Tora L., The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Oncogene 18, 8000&#x2013;8010 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10637511</ArticleId></ArticleIdList></Reference><Reference><Citation>Shing D. C., et al. , FUS/ERG gene fusions in Ewing&#x2019;s tumors. Cancer Res. 63, 4568&#x2013;4576 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12907633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovar H., Dr. Jekyll and Mr., Hyde: The two faces of the FUS/EWS/TAF15 protein family. Sarcoma 2011, 1&#x2013;13 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3005952</ArticleId><ArticleId IdType="pubmed">21197473</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J. C., et al. , FUS is sequestered in nuclear aggregates in ALS patient fibroblasts. Mol. Biol. Cell 25, 2571&#x2013;2578 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4148247</ArticleId><ArticleId IdType="pubmed">25009283</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H., et al. , ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Invest. 124, 981&#x2013;999 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik A. M., et al. , Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. eLife 7, e35977 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050042</ArticleId><ArticleId IdType="pubmed">30015619</ArticleId></ArticleIdList></Reference><Reference><Citation>Shackelford D. A., Kaufman J. F., Korman A. J., Strominger J. L., HLA-DR antigens: Structure, separation of subpopulations. Gene cloning and function. Immunol. Rev. 66, 133&#x2013;187 (1982).</Citation><ArticleIdList><ArticleId IdType="pubmed">6813244</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakikes I., et al. , Interaction of HLA-DR and CD74 at the cell surface of antigen-presenting cells by single particle image analysis. FASEB J. 26, 4886&#x2013;4896 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22889831</ArticleId></ArticleIdList></Reference><Reference><Citation>Basler M., Kirk C. J., Groettrup M., The immunoproteasome in antigen processing and other immunological functions. Curr. Opin. Immunol. 25, 74&#x2013;80 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23219269</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy M. K., Weinberg J. B., The immunoproteasome and viral infection: A complex regulator of inflammation. Front. Microbiol. 6, 21 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310299</ArticleId><ArticleId IdType="pubmed">25688236</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock K. L., York I. A., Goldberg A. L., Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5, 670&#x2013;677 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15224092</ArticleId></ArticleIdList></Reference><Reference><Citation>Figliuolo da Paz V., Ghishan F. K., Kiela P. R., Emerging roles of disabled homolog 2 (DAB2) in immune regulation. Front. Immunol. 11, 580302 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7593574</ArticleId><ArticleId IdType="pubmed">33178208</ArticleId></ArticleIdList></Reference><Reference><Citation>Podle&#x15b;ny-Drabiniok A., Marcora E., Goate A. M., Microglial phagocytosis: A disease-associated process emerging from Alzheimer&#x2019;s disease genetics. Trends Neurosci. 43, 965&#x2013;979 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9080913</ArticleId><ArticleId IdType="pubmed">33127097</ArticleId></ArticleIdList></Reference><Reference><Citation>Paludan S. R., Pradeu T., Masters S. L., Mogensen T. H., Constitutive immune mechanisms: Mediators of host defence and immune regulation. Nat. Rev. Immunol. 21, 137&#x2013;150 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418297</ArticleId><ArticleId IdType="pubmed">32782357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlyuk N., et al. , &#x201c;S100 proteins in the innate immune response to pathogens&#x201d; in Calcium-Binding Proteins of the EF-Hand Superfamily, Heizmann C. W., Ed. (Springer, New York, 2019), pp. 275&#x2013;290.</Citation></Reference><Reference><Citation>Yu D. T., McCune J. M., Fu S. M., Winchester R. J., Kunkel H. G., Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens. J. Exp. Med. 152, 89s&#x2013;98s (1980).</Citation><ArticleIdList><ArticleId IdType="pubmed">6967943</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker D. C., T cell-dependent B cell activation. Annu. Rev. Immunol. 11, 331&#x2013;360 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8476565</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;der B., The multifaceted roles of the invariant chain CD74&#x2014;More than just a chaperone. Biochim. Biophys. Acta Mol. Cell Res. 1863, 1269&#x2013;1281 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27033518</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y., Ohzeki H., Sugano N., Hiraga K., Transcription Modulation by a Rat Nuclear Scaffold Protein, P130, and a Rat Highly Repetitive DNA Component or Various Types of Animal and Plant Matrix or Scaffold Attachment Regions. Biochem. Biophys. Res. Commun. 279, 282&#x2013;287 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11112453</ArticleId></ArticleIdList></Reference><Reference><Citation>LeibundGut-Landmann S., et al. , Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34, 1513&#x2013;1525 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15162420</ArticleId></ArticleIdList></Reference><Reference><Citation>Reith W., LeibundGut-Landmann S., Waldburger J.-M., Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 5, 793&#x2013;806 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16200082</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner T. B., Li A., Kobayashi K. S., NLRC5: A newly discovered MHC class I transactivator (CITA). Microb. Infect. 14, 477&#x2013;484 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3323719</ArticleId><ArticleId IdType="pubmed">22209772</ArticleId></ArticleIdList></Reference><Reference><Citation>Dello Russo C., et al. , The human microglial HMC3 cell line: Where do we stand? A systematic literature review. J. Neuroinflammation 15, 259 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6131758</ArticleId><ArticleId IdType="pubmed">30200996</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., et al. , HLA-DRA/HLA-DRB5 polymorphism affects risk of sporadic ALS and survival in a southwest Chinese cohort. J. Neurol. Sci. 373, 124&#x2013;128 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28131168</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D. A., et al. , Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 19, 4160&#x2013;4175 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M. E., et al. , C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature 585, 96&#x2013;101 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P. A., Lee J. D., Woodruff T. M., Henderson R. D., The peripheral immune system and amyotrophic lateral sclerosis. Front. Neurol. 11, 279 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186478</ArticleId><ArticleId IdType="pubmed">32373052</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C., et al. , Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis. eLife 11, e74065 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8923665</ArticleId><ArticleId IdType="pubmed">35287794</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouzolles M., Oburoglu L., Taylor N., Zimmermann V. S., Hematopoietic stem cell lineage specification. Curr. Opin. Hematol. 23, 311&#x2013;317 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27135980</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. Y., Hong S.-H., Hematopoietic stem cells and their roles in tissue regeneration. Int. J. Stem Cells 13, 1&#x2013;12 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7119209</ArticleId><ArticleId IdType="pubmed">31887851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari G., Thrasher A. J., Aiuti A., Gene therapy using haematopoietic stem and progenitor cells. Nat. Rev. Genet. 22, 216&#x2013;234 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33303992</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt J. I., Tajti J., Appel S. H., Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 50, 30&#x2013;36 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8093428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L., et al. , Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 132, 391&#x2013;411 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves M., et al. , Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 5, 213&#x2013;219 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15799549</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm&#xf8;y T., T cells in amyotrophic lateral sclerosis. Eur. J. Neurol. 15, 360&#x2013;366 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18266871</ArticleId></ArticleIdList></Reference><Reference><Citation>Puentes F., Malaspina A., van Noort J. M., Amor S., Non-neuronal cells in ALS: Role of glial, immune cells and blood-CNS barriers: Non-neuronal cells in ALS. Brain Pathol. 26, 248&#x2013;257 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029111</ArticleId><ArticleId IdType="pubmed">26780491</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J. S., et al. , Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue: Dendritic cells and MCP-1 in ALS. Ann. Neurol. 55, 221&#x2013;235 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Antel J. P., Becher B., Ludwin S. K., Prat A., Quintana F. J., Glial cells as regulators of neuroimmune interactions in the central nervous system. J. Immunol. 204, 251&#x2013;255 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31907266</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang F., Role of neuroinflammation in amyotrophic lateral sclerosis: Cellular mechanisms and therapeutic implications. Front. Immunol. 8, 1005 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaspina A., Puentes F., Amor S., Disease origin and progression in amyotrophic lateral sclerosis: An immunology perspective. Int. Immunol. 27, 117&#x2013;129 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25344935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Malmierca P., et al. , Antigen presentation safeguards the integrity of the hematopoietic stem cell pool. Cell Stem Cell 29, 760&#x2013;775.e10 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9202612</ArticleId><ArticleId IdType="pubmed">35523139</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetters S. T. T., Gomez-Nicola D., Garcia-Vallejo J. J., Van Kooyk Y., Neuroinflammation: Microglia and T cells get ready to tango. Front. Immunol. 8, 1905 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5788906</ArticleId><ArticleId IdType="pubmed">29422891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D. R., Appel S. H., Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J. Neuroimmu. Pharmacol. 8, 888&#x2013;899 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., et al. , Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 364, 89&#x2013;93 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A., et al. , C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice. Sci. Rep. 6, 23204 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J. G., et al. , C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324&#x2013;1329 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Satin Z. A., Bayat E., ALS-like disorder in three HIV-positive patients: Case series. Case Rep. Neurol. 13, 59&#x2013;64 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7923715</ArticleId><ArticleId IdType="pubmed">33708095</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen L. N., et al. , HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy. Neurology 87, 1756&#x2013;1762 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089528</ArticleId><ArticleId IdType="pubmed">27664983</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGowan D. J. L., Scelsa S. N., Waldron M., An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 57, 1094&#x2013;1097 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11571341</ArticleId></ArticleIdList></Reference><Reference><Citation>Quevedo-Ramirez A., et al. , Lateral amyotrophic sclerosis-like onset after combined antiretroviral treatment initiation. IDCases 22, e00994 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7642845</ArticleId><ArticleId IdType="pubmed">33194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A., Berger J. R., ALS syndrome in patients with HIV-1 infection. J. Neurol. Sci. 240, 59&#x2013;64 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16236322</ArticleId></ArticleIdList></Reference><Reference><Citation>Siomi H., Dreyfuss G., A nuclear localization domain in the hnRNP A1 protein. J. Cell Biol. 129, 551&#x2013;560 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120450</ArticleId><ArticleId IdType="pubmed">7730395</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura Y., et al. , Matrin3 binds directly to intronic pyrimidine-rich sequences and controls alternative splicing. Genes Cells 22, 785&#x2013;798 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28695676</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlister G. C., et al. , Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. Anal. Chem. 84, 7469&#x2013;7478 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715028</ArticleId><ArticleId IdType="pubmed">22880955</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., et al. , Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424&#x2013;429 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3084903</ArticleId><ArticleId IdType="pubmed">21478862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuris J. A., et al. , Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73&#x2013;80 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4289409</ArticleId><ArticleId IdType="pubmed">25357182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., et al. , Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72 -ALS/FTD. Proc. Natl. Acad. Sci. U.S.A. 116, 9628&#x2013;9633 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511021</ArticleId><ArticleId IdType="pubmed">31019093</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>